Iconic Labs plc (ICON) AI Stock Analysis

• Market Cap: £347.10K
• Dividend Yield: N/A
• Average Volume (3M): 60.90K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.66
• Revenue Growth: N/A
• EPS Growth: -152.00%
• Country: UK
• Employees: 4
• Sector: Communication Services
• Sector Strength: 97
• Industry: Advertising Agencies
• EPS (TTM): -0.02
• Shares Outstanding: 13,884,027
• 10 Day Avg. Volume: 30,612
• 30 Day Avg. Volume: 60,904
• PEG Ratio: <0.01
• Price to Book (P/B): -0.07
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: 2.50p ▲(0.00% Upside)

The score is held down primarily by severely distressed financial performance (near-zero revenue, persistent operating losses, negative equity, and ongoing cash burn). Technical indicators are only mildly supportive and do not offset the fundamental risk, while valuation is constrained by a negative P/E and no dividend yield data.

Positive Factors

Management Transparency

The announcement of the AGM and the availability of proxy forms indicate a commitment to transparency and shareholder engagement, which can enhance trust and stability in the long term.

Strategic Partnerships

By pursuing strategic partnerships, Iconic Labs aims to expand its market reach and enhance service offerings, which can lead to sustainable revenue growth and competitive advantages.

Content and Marketing Expertise

The company's expertise in digital content and marketing positions it well to capitalize on the growing demand for innovative media solutions, supporting long-term growth.

Negative Factors

Financial Distress

Significant financial distress across key financial statements suggests challenges in maintaining operations and limits the company's ability to invest in growth, posing long-term risks.

High Leverage

High leverage and negative equity indicate financial instability, which can constrain the company's strategic options and increase vulnerability to economic downturns.

Acquisition Challenges

Failure to complete acquisitions and reliance on short-term funding highlight operational challenges and uncertainty, impacting long-term strategic growth and stability.

Iconic Labs plc Business Overview & Revenue Model

Company Description

Iconic Labs Plc engages in media and technology business, focuses providing online marketing, and content and technology driven products. It also engages in digital and social media publishing activities. The company offers advisory services to clients on their businesses; and delivers campaigns, as well as provides creative services to its clients. Its activities include monthly insights, content creation and distribution, post campaign analysis, and combining with online media brands. The company was formerly known as WideCells Group PLC and changed its name to Iconic Labs Plc in July 2019. Iconic Labs Plc was founded in 2012 and is based in London, the United Kingdom.

How the Company Makes Money

Iconic Labs plc generates revenue through a multi-faceted approach that includes advertising and content creation. The company partners with brands to develop tailored digital marketing campaigns that leverage its expertise in content production and distribution. By utilizing advanced data analytics, Iconic Labs optimizes campaign performance and audience engagement, ensuring value for its clients. Additionally, the company explores strategic partnerships and collaborations to enhance its service offerings and expand its market reach. Revenue is primarily driven by the fees charged for these services, as well as potential revenue-sharing agreements with partners and clients.

Iconic Labs plc Financial Statement Overview

Summary

Iconic Labs plc shows significant financial distress across all key financial statements. The income statement reveals a lack of revenue and profitability, while the balance sheet highlights high leverage and negative equity. Cash flow analysis indicates struggles in generating cash from operations. The company is in a precarious financial position, with limited positive indicators for stability or growth.

Income Statement

The company's revenue has consistently been negligible over the years, with an absence of gross profit. The net income fluctuated but was negative in most years, indicating poor profitability. The recent improvement in net income is a positive sign, but overall, the income statement shows a lack of revenue growth and weak margins.

Balance Sheet

The company is highly leveraged with negative stockholders' equity, indicating financial distress. The debt-to-equity ratio is not calculable due to negative equity, and the equity ratio is also negative. These metrics highlight significant financial instability and potential risk due to high liabilities relative to assets.

Cash Flow

Operating cash flow has been consistently negative, indicating challenges in generating cash from operations. The free cash flow also shows negative trends, although there is some improvement in recent financing activities. The operating cash flow to net income ratio is volatile, which raises concerns about cash generation versus accounting profits.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	0.00	0.00	0.00	0.00	26.82K	509.17K
Gross Profit	-30.00	0.00	0.00	0.00	26.24K	509.10K
EBITDA	-615.12K	-555.12K	-246.05K	4.77M	-759.60K	-3.10M
Net Income	-628.23K	-628.23K	418.95K	4.77M	-762.00K	-7.70M
Balance Sheet
Total Assets	95.04K	95.04K	139.34K	50.24K	6.00	154.06K
Cash, Cash Equivalents and Short-Term Investments	35.74K	35.74K	129.31K	50.24K	5.00	50.93K
Total Debt	3.08M	3.08M	2.65M	1.94M	2.42M	2.42M
Total Liabilities	4.06M	4.06M	2.86M	3.69M	8.94M	8.33M
Stockholders Equity	-3.96M	-3.96M	-2.72M	-3.64M	-8.94M	-8.18M
Cash Flow
Free Cash Flow	-296.52K	0.00	-802.71K	-919.76K	-50.92K	1.15M
Operating Cash Flow	-448.07K	-448.07K	-802.71K	-919.76K	-50.92K	1.15M
Investing Cash Flow	0.00	0.00	0.00	0.00	0.00	0.00
Financing Cash Flow	354.50K	354.50K	881.78K	970.00K	0.00	-1.28M

Iconic Labs plc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SAL	75 Outperform	£4.15M	8.40	14.92%	―	20.20%	57.77%
Sector *	60 Neutral	$48.67B	4.58	-11.27%	4.14%	2.83%	-41.78%
DNM	59 Neutral	£4.95M	11.79	4.93%	―	―	―
MDZ	57 Neutral	£1.44M	―	-3.05%	―	55.13%	―
ICON	42 Neutral	£347.10K	-0.50	―	―	―	-152.00%
MIRI	40 Neutral	£1.37M	-0.02	-114.93%	―	―	―
GVMH	40 Underperform	£577.72K	-0.98	―	―	―	―

Iconic Labs plc Corporate Events

Iconic Labs Wins Shareholder Backing for All AGM Resolutions

Iconic Labs plc reported that shareholders approved all seven resolutions put to its Annual General Meeting held on 31 December 2025, including the adoption of accounts for the year ended 30 June 2025, the reappointment of RPG Chartered Accountants as auditors, and the re-election of director Bela Lendvai-Lintner. Investors also backed new Articles of Association and granted the board authority to allot shares and issue equity securities, reinforcing management’s flexibility over capital structure and governance as the company pursues its strategic objectives.

The most recent analyst rating on (GB:ICON) stock is a Hold with a £2.50 price target. To see the full list of analyst forecasts on Iconic Labs plc stock, see the GB:ICON Stock Forecast page.

Iconic Labs PLC Announces Date for Annual General Meeting

Iconic Labs PLC, a company listed on the London Stock Exchange under the ticker ICON, has announced the scheduling of its Annual General Meeting (AGM) for December 31, 2025. The meeting will take place at the offices of AMBA Company Secretarial Services Ltd in London. This announcement is significant for shareholders as it provides them with the opportunity to participate in the company’s governance and decision-making processes.

Iconic Labs Plc Announces Annual Results and Strategic Focus

Iconic Labs Plc has announced its annual results for the year ending 30 June 2025. The company, which had its shares suspended, has resumed trading on the London Stock Exchange. Despite not proceeding with a planned acquisition of ITS Holdings 2024 Ltd, Iconic is committed to finding new acquisition targets that meet its strategic goals and market requirements. The company faces risks related to revenue generation, funding, and share dilution, but remains focused on reducing costs and identifying suitable acquisition opportunities to ensure long-term growth and value for shareholders.